These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32276945)

  • 1. Fibroblast Growth Factor 23 and the Last Mile.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2020 Sep; 15(9):1355-1357. PubMed ID: 32276945
    [No Abstract]   [Full Text] [Related]  

  • 2. Focus on vitamin D therapy in chronic kidney disease.
    Tentori F
    J Nephrol; 2007; 20(5):511-4. PubMed ID: 17918134
    [No Abstract]   [Full Text] [Related]  

  • 3. Disordered FGF23 and mineral metabolism in children with CKD.
    Portale AA; Wolf M; Jüppner H; Messinger S; Kumar J; Wesseling-Perry K; Schwartz GJ; Furth SL; Warady BA; Salusky IB
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):344-53. PubMed ID: 24311704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.
    Hamano T
    Clin Exp Nephrol; 2018 Apr; 22(2):249-256. PubMed ID: 29270765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.
    Malhotra R; Katz R; Hoofnagle A; Bostom A; Rifkin DE; Mcbride R; Probstfield J; Block G; Ix JH
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):36-44. PubMed ID: 29208626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease.
    Sonkar SK; Bhutani M; Sonkar GK; Pandey SK; Chandra S; Bhosale V
    Saudi J Kidney Dis Transpl; 2017; 28(4):758-763. PubMed ID: 28748877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKD-mineral and bone disorder: core curriculum 2011.
    Moorthi RN; Moe SM
    Am J Kidney Dis; 2011 Dec; 58(6):1022-36. PubMed ID: 22018457
    [No Abstract]   [Full Text] [Related]  

  • 9. CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
    Melamed ML; Buttar RS; Coco M
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):262-9. PubMed ID: 27324680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.
    Haffner D; Schaefer F
    Pediatr Nephrol; 2013 Apr; 28(4):537-45. PubMed ID: 22893310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects.
    Martin KJ; Bell G; Pickthorn K; Huang S; Vick A; Hodsman P; Peacock M
    Nephrol Dial Transplant; 2014 Feb; 29(2):385-92. PubMed ID: 24235081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
    Isakova T; Wahl P; Vargas GS; Gutiérrez OM; Scialla J; Xie H; Appleby D; Nessel L; Bellovich K; Chen J; Hamm L; Gadegbeku C; Horwitz E; Townsend RR; Anderson CA; Lash JP; Hsu CY; Leonard MB; Wolf M
    Kidney Int; 2011 Jun; 79(12):1370-8. PubMed ID: 21389978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
    Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
    J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
    Ennis JL; Worcester EM; Coe FL; Sprague SM
    J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study.
    Fortier C; Mac-Way F; De Serres SA; Marquis K; Douville P; Desmeules S; Larivière R; Agharazii M
    Am J Hypertens; 2014 Nov; 27(11):1346-54. PubMed ID: 24695980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K
    Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D analogues: how do they differ and what is their clinical role?
    Steddon SJ; Schroeder NJ; Cunningham J
    Nephrol Dial Transplant; 2001 Oct; 16(10):1965-7. PubMed ID: 11572878
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)
    Kritmetapak K; Losbanos L; Berent TE; Ashrafzadeh-Kian SL; Algeciras-Schimnich A; Hines JM; Singh RJ; Kumar R
    BMC Nephrol; 2021 Mar; 22(1):114. PubMed ID: 33784965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
    Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.